Physician profile
Subhash C Gupta
NPI 1881652956
$2,244.23
in general payments reported to CMS, 2019-2025
17 companies · $264 in 2025
The $264 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $636 · 2020: $38.58 · 2021: $378 · 2022: $506 · 2023: $421 · 2025: $264.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $603 · Gift: $81.81.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $603.09 |
| Gift | $81.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Braintree Laboratories, INC. | $374.21 | 2019-2023 | Suflave |
| Novo Nordisk INC | $271.80 | 2020-2022 | |
| Janssen Pharmaceuticals, INC | $249.98 | 2021-2022 | |
| Amgen INC. | $245.85 | 2023-2025 | Repatha, Repatha |
| Bayer Healthcare Pharmaceuticals INC. | $226.41 | 2022-2023 | |
| Glaxosmithkline, LLC. | $166.78 | 2019-2023 | |
| Lilly USA, LLC | $125.00 | 2025 | Zepbound |
| Pfizer INC. | $124.99 | 2019 | |
| Integra Lifesciences Corporation | $105.52 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $87.36 | 2022 | |
| Janssen Biotech, INC. | $64.98 | 2019-2020 | |
| Redhill Biopharma INC. | $56.94 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $47.37 | 2019-2023 | Xifaxan |
| Coloplast Corp | $35.11 | 2022 | |
| Tepha INC | $30.88 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $18.28 | 2025 | Vabysmo |
| Angiodynamics, INC. | $12.77 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Subhash Gupta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.